AI Science Tracker
EN

Low-Dose 68 Ga-PSMA Prostate PET/MRI Imaging Using Deep Learning Based on MRI Priors.

Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences · 26 Jan 2022 · medicine

Discovery

Low-Dose 68 Ga-PSMA Prostate PET/MRI Imaging Using Deep Learning Based on MRI Priors.

Source check: Source checked. Not independent scientific confirmation.

Finding: In 41 patients, image quality and physician scoring improved over low-dose source images; diagnosis was reported unaffected at reduced dose. External replication and prospective utility were not established in the reviewed material.

Technology: Deep learning using MRI priors synthesized full-dose-like PSMA PET from low-dose images.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Deep learning using MRI priors synthesized full-dose-like PSMA PET from low-dose images.
Test and result
In 41 patients, image quality and physician scoring improved over low-dose source images; diagnosis was reported unaffected at reduced dose.
Limitation / still unknown
External replication, causal effects and prospective utility were not established in the reviewed material.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.818329/full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.